Resources

Filter:

Read more

Newsweek World's Best Digital Health Companies 2024

Newsweek Selects Caristo Diagnostics as One of World’s Best Digital Health Companies

Caristo Diagnostics, a leading cardiac disease diagnostics company, has been named by Newsweek as one of World’s Best Digital Health…

Read more

Surrey Cardiovascular Clinic and Caristo Diagnostics Launch Employee Heart Wellness and Disease Prevention Program for UK Employers

Caristo’s AI technology predicts heart attack risk for employee wellness initiative from respected centre of excellence OXFORD, England and SURREY, England , April 23,…

Read more

Caristo and Abcentra Collaboration

American College of Cardiology Presentation Highlights Promising Results Showing Potential to Reduce Coronary Inflammation with Abcentra’s Orticumab

Caristo’s CaRi-Heart® AI Technology used to monitor effects of Orticumab detected a reduction in coronary inflammation and predicted a 50%…

Read more

Quote by Dr Jonathan Rodrigues, Heart & Lung Health

Heart & Lung Health selects Caristo Diagnostics AI technology to provide early diagnosis of coronary artery disease UK-wide

UK-wide radiologist network to deploy Caristo’s pioneering CaRi-Heart® solution  Oxford, March 19, 2024— Heart & Lung Health (HLH), a UK-wide network of…

Read more

Caristo’s CaRi-Heart® technology addresses the gender gap in understanding cardiovascular disease risk in women

Cardiovascular risk prediction models based on traditional risk factors underestimate risk in women – review article by European Atherosclerosis Society…

Read more

Agepha Pharma partners with Caristo Diagnostics

Agepha Pharma and Caristo Diagnostics Team Up to Fight Coronary Inflammation

Press Release Agepha Pharma, a leading multinational pharmaceutical company with the first FDA-approved anti-inflammatory cardiovascular treatment (LODOCO®– colchicine, 0.5 mg…

Read more

AHA Late Breaking Science Presentation

American Heart Association Late-Breaking Science Presentation Reveals Majority of Adverse Cardiac Events Occur Among Patients Without Obstructive Coronary Artery Disease but Risks Are Detectable by Novel AI

Press Release Caristo’s AI Technology for Coronary Inflammation Measurement and Risk Assessment Can Transform Risk Stratification and Management of Patients…

Read more

World Heart Day Programme by British Heart Foundation

British Heart Foundation Features Breakthrough Heart Attack Prevention Technology in Online News Programme for World Heart Day

Press Release British Heart Foundation Features Breakthrough Heart Attack Prevention Technology in Online News Programme for World Heart Day CaRi-Heart®…


View Resources Archive

Get in touch for more information.